about
Highly diversified Zika viruses imported to China, 2016Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAbMonoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigsEpidemiology, Evolution, and Recent Outbreaks of Avian Influenza Virus in ChinaTransmission of Ebola viruses: what we know and what we do not knowMore Challenges From Ebola: Infection of the Central Nervous SystemZika virus in the testes: should we be worried?An mRNA-based vaccine strategy against ZikaT-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in MiceAdeno-Associated Virus Serotype 9-Expressed ZMapp in Mice Confers Protection Against Systemic and Airway-Acquired Ebola Virus Infection.Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice.Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza.Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virusDeep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over timePost-exposure therapy of filovirus infections.Experimental countermeasures against Ebola virus: current progress and an ethical conundrum.Reversion of advanced Ebola virus disease in nonhuman primates with ZMappThe multiple roles of sGP in Ebola pathogenesisEbola virus transmission in guinea pigs.Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreakConsensus statement on iodine deficiency disorders in Hong Kong.A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola InfectionHighly Pathogenic Avian Influenza A(H5N1) Virus Struck Migratory Birds in China in 2015Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in Rodents.Development and Characterization of a Guinea Pig-Adapted Sudan Virus.Can Ebola virus become endemic in the human population?Changes in the Length of the Neuraminidase Stalk Region Impact H7N9 Virulence in Mice.Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection.The metabolic syndrome in children and adolescents - an IDF consensus report.Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.Cyclophilin A protects mice against infection by influenza A virus.Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primatesFerrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.First documented case of avian influenza (H5N1) virus infection in a lion.Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profiles.An unexpected N-terminal loop in PD-1 dominates binding by nivolumab.
P50
Q24289683-132B1B55-0009-4CE8-BBDA-03F938213E9AQ24594601-5B4AEF0B-4D38-463D-81B6-39E067689F4AQ24604416-B8959A26-C03E-4FD9-A5DB-B67CD8C74F8AQ26829196-9CDFCC9C-BCE0-444C-949A-975AA4D986F9Q28083565-8A2AC0CD-DD64-48BE-854D-413202A1FEFAQ28390883-DA4DE33E-31BF-4985-A4B4-46007E39AA1AQ28582905-C4B82ECD-EE0C-4C75-A176-7A25F729A6FBQ29352285-B5331A41-F315-48FC-93F7-A24787B97634Q30241347-80D0AED8-7C30-4A42-8F74-ECD5A5B122C3Q30361326-43EF908F-E732-4EA0-8B6C-9A98A7CA3FE3Q30375073-F22FDC28-1A88-4E7C-BAF3-0936DBEBE929Q30393562-848E548B-880B-4086-A98E-9C342F5DD5A9Q30396959-DE3EFBC6-E2D4-4F4C-B6F2-1145D7052A80Q30431225-D317919C-9A19-4B4C-9376-CB59F090408FQ33417197-73D7DEB0-F1A5-4455-94AF-07BE61C2252FQ33794406-972E7D1F-01CF-4CAA-B7BA-2A4729867D15Q34040813-2AB39AD5-074B-4D33-A721-F01B6B195285Q34373270-1997EC2F-608A-417F-9BAE-69FEAA496C24Q34426585-D8DF4A85-8F15-483F-A9AF-86DF5F46FEC9Q34869463-D385636F-4E0C-423C-B6F8-25CA87332841Q34991054-88C8649A-DBD0-4BF5-9F9D-949738A21313Q35598919-1C15C508-ECC5-45D8-A052-1830C519C8F1Q35602082-28CC5A51-B52C-48DA-A9EF-B0A6D4BEC576Q35917501-6885668D-F7DF-48F2-BE3A-96233CFBF4C6Q35936046-04B64C1D-F020-4280-B973-A1A9E9DB4414Q36043199-05E09CB0-C373-4DFA-84F2-37F538BAC474Q36433538-DD02297B-106B-4EA1-93BA-3950A6ED759DQ36433906-426C9CCB-35A6-49E3-A9B4-AEF5588D360FQ36447887-BFE5CFED-1F4A-4E6E-ABD0-1797A242C8BAQ36524026-0F78F068-866A-42C9-84F5-C14820404358Q36789989-21B1E4BA-3AE1-4FC4-90FE-28BF2FC7BFCAQ36938565-C1DDADA6-5C0C-4694-BB71-5C08078E2A29Q36960705-DD7180A5-9ACE-484B-A0BB-331168B74F58Q36995725-0414B028-BA2D-480B-A5D7-DF16C4003C4AQ37049668-8D404093-1CFE-4745-8F99-66C937DD56EFQ37213207-29B4FA86-8B33-4192-ACBE-844D2D982718Q37300391-53C681D4-A6B1-4AED-BA5C-2216A3AFCAB9Q37529519-4E5B49E2-95CB-4600-9C3F-373960D68AD4Q37560160-3259F9D6-6295-441B-B5D2-43FA65937FFDQ37637845-C32D3C3B-17BD-45ED-92AF-E455A45D0328
P50
name
Gary Wong
@ast
Gary Wong
@en
Gary Wong
@nl
type
label
Gary Wong
@ast
Gary Wong
@en
Gary Wong
@nl
prefLabel
Gary Wong
@ast
Gary Wong
@en
Gary Wong
@nl